α2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis

47Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Tissue plasminogen activator (t-PA) causes fibrinogen proteolysis when α2-antiplasmin levels fall, and this may contribute to t-PA-induced hemorrhage. Because clot-bound plasmin is protected from α2-antiplasmin inhibition, we tested the possibility that α2-antiplasmin supplementation would block t-PA-induced fibrinogenolysis and bleeding without affecting thrombolysis. When added to human or rabbit plasma, α2-antiplasmin inhibits t-PA-induced fibrinogenolysis, but has little effect on the lysis of 125I-fibrin clots. To examine its effect in vivo, rabbits with preformed 125I-labeled-jugular vein thrombi were randomized to receive t-PA, t-PA and α2-antiplasmin, or saline. α2-Antiplasmin infusion produced a modest decrease in t-PA-induced thrombolysis (from 40.2% to 30.1%, P = 0.12), but reduced fibrinogen consumption from 87% to 27% (P = 0.0001), and decreased blood loss from standardized ear incisions from 5,594 to 656 μl (P < 0.0001). We hypothesize that α2-antiplasmin limits t-PA-induced hemorrhage by inhibiting fibrinogenolysis and subsequent fragment X formation because (a) SDS-PAGE and immunoblot analysis indicate less fragment X formation in α2-antiplasmin treated animals, and (b) when added to a solution of fibrinogen and plasminogen clotted with thrombin in the presence of t-PA, fragment X shortens the lysis time in a concentration-dependent fashion. These findings suggest that fragment X incorporation into hemostatic plugs contributes to t-PA-induced bleeding. By blocking t-PA-mediated fibrinogenolysis, α2-antiplasmin supplementation may improve the safety of fibrin-specific plasminogen activators.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Weitz, J. I., Leslie, B., Hirsh, J., & Klement, P. (1993). α2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis. Journal of Clinical Investigation, 91(4), 1343–1350. https://doi.org/10.1172/jci116335

Readers' Seniority

Tooltip

Professor / Associate Prof. 4

33%

PhD / Post grad / Masters / Doc 4

33%

Researcher 3

25%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

67%

Biochemistry, Genetics and Molecular Bi... 2

17%

Chemical Engineering 1

8%

Social Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free